Corbus Pharmaceuticals Holdings (CRBP) Change in Account Payables (2013 - 2025)

Corbus Pharmaceuticals Holdings' Change in Account Payables history runs 13 years deep, the most recent figure standing at -$1.3 million for Q3 2025.

• In Q3 2025, Change in Account Payables fell 165.37% year-over-year to -$1.3 million; the TTM figure through Sep 2025 stood at -$107000.0 (up 93.2% YoY), while the FY2024 annual figure was $1.6 million, up 55.93% from the prior year.
• Change in Account Payables was -$1.3 million for Q3 2025 at Corbus Pharmaceuticals Holdings, down from $175000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $3.2 million in Q3 2023 to a low of -$3.7 million in Q1 2021.
• Historically, Change in Account Payables has averaged -$282480.6 across 5 years, with a median of -$759706.0 in 2021.
• The sharpest annual moves came in 2023 and 2024: Change in Account Payables surged 493.74% in 2023, then sank 586.81% in 2024.
• A 5-year view of Change in Account Payables shows it stood at -$759706.0 in 2021, then surged by 229.06% to $980459.0 in 2022, then sank by 252.89% to -$1.5 million in 2023, then soared by 211.94% to $1.7 million in 2024, then tumbled by 176.04% to -$1.3 million in 2025.
• The last three Change in Account Payables figures came in at -$1.3 million (Q3 2025), $175000.0 (Q2 2025), and -$684000.0 (Q1 2025), per Business Quant data.